Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors.

J Hum Virol. 1997 Nov-Dec;1(1):30-6. Unique Identifier : AIDSLINE MED/99211132
McLinden RJ; Lewis B; Michael NL; Redfield RR; Birx DL; Kim JH; Department of Medicine, University of Maryland, Baltimore, USA.

Abstract: OBJECTIVE: To determine the relation between P53 tumor suppressor RNA expression and human immunodeficiency virus (HIV) disease progression. STUDY DESIGN/METHODS: A quantitative assay of P53 RNA expression was used to analyze a cohort of HIV-negative persons. The assay was then used in longitudinal and cross-sectional studies of HIV slow and rapid progressors. RESULTS: We demonstrate first that P53 expression in peripheral blood mononuclear cells from HIV-1-seronegative persons is minimal. Longitudinal studies in a small cohort of HIV-1-infected slow and rapid progressors reveal that rapid progressors seem to have greater P53 RNA expression over time. This was validated in a cohort of 26 HIV-1-infected persons in whom the expression of P53 RNA was significantly greater in persons with rapid progression of HIV-1 disease. CONCLUSION: These data suggest that P53 RNA expression may play a role in the pathogenesis of HIV-1 disease, though the mechanism of this interaction remains unknown.
Keywords: JOURNAL ARTICLE Animal Cell Cycle CD4 Lymphocyte Count CHO Cells Disease Progression Gene Expression *Genes, Suppressor, Tumor Hamsters Human HIV Infections/BLOOD/*GENETICS/IMMUNOLOGY/VIROLOGY HIV Seronegativity HIV-1/PHYSIOLOGY Protein p53/ANALYSIS/BLOOD/*GENETICS RNA, Messenger/ANALYSIS Support, U.S. Gov't, P.H.S. Viral LoadKWDjournalarticleanimalcellcyclecd4lymphocytecountchocellsdiseaseprogressiongeneexpressionKWDgenes,suppressor,tumorhamstershumanhivinfections/blood/KWDgenetics/immunology/virologyhivseronegativityhiv-1/physiologyproteinp53/analysis/blood/KWDgeneticsrna,messenger/analysissupport,uKWDsKWDgov't,pKWDhKWDsKWDviralload
990730
A9971149

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .